Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS302 in Intraocular Lens Replacement
NCT01579565Phase 3Completed
- Sponsor
- Omeros Corporation
- Start
- Apr 2012
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of phenylephrine + ketorolac in cataract, miosis, postoperative pain, sponsored by Omeros Corporation. Started Apr 2012; status: completed.
02
Drugs
phenylephrine + ketorolac
03
Conditions
cataractmiosispostoperative pain
Beyond the preview
Go deeper on NCT01579565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579565.